DE202014007178U1 - Pharmaceutical effective oil mixture and device for its use - Google Patents
Pharmaceutical effective oil mixture and device for its use Download PDFInfo
- Publication number
- DE202014007178U1 DE202014007178U1 DE201420007178 DE202014007178U DE202014007178U1 DE 202014007178 U1 DE202014007178 U1 DE 202014007178U1 DE 201420007178 DE201420007178 DE 201420007178 DE 202014007178 U DE202014007178 U DE 202014007178U DE 202014007178 U1 DE202014007178 U1 DE 202014007178U1
- Authority
- DE
- Germany
- Prior art keywords
- oil mixture
- oil
- dosing
- navel
- push rod
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 239000003921 oil Substances 0.000 claims abstract description 13
- 235000019198 oils Nutrition 0.000 claims abstract description 13
- 235000005976 Citrus sinensis Nutrition 0.000 claims abstract description 3
- 240000002319 Citrus sinensis Species 0.000 claims abstract description 3
- 239000010477 apricot oil Substances 0.000 claims abstract description 3
- 239000001342 boswellia carteri birdw. oil Substances 0.000 claims abstract description 3
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims abstract description 3
- 239000010502 orange oil Substances 0.000 claims abstract description 3
- 238000007789 sealing Methods 0.000 claims description 8
- 210000001015 abdomen Anatomy 0.000 claims description 6
- 210000003815 abdominal wall Anatomy 0.000 claims description 6
- 239000011505 plaster Substances 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 239000011435 rock Substances 0.000 claims description 2
- 239000011037 rose quartz Substances 0.000 claims description 2
- 210000003954 umbilical cord Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000008177 pharmaceutical agent Substances 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000002826 placenta Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003606 umbilical vein Anatomy 0.000 description 2
- BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000289419 Metatheria Species 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000001644 umbilical artery Anatomy 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Pharmazeutisch wirksame Ölmischung, bei der 100 ml bestehen aus: a) 70 ml Aprikosenöl b) 10 ml Blutorangenöl c) 15 ml Lavendelöl d) 5 ml WeihrauchölPharmaceutically effective oil mixture of which 100 ml consists of: a) 70 ml apricot oil b) 10 ml blood orange oil c) 15 ml lavender oil d) 5 ml frankincense oil
Description
Die Erfindung betrifft eine pharmazeutisch wirksame Ölmischung und eine Vorrichtung zu ihrer AnwendungThe invention relates to a pharmaceutically active oil mixture and a device for its use
Pharmazeutische Wirkstoffe werden meist oral in Pulverform, als Flüssigkeiten oder in der Form von Tabletten oder Kapseln dem menschlichen Körper zugeführt. Eine andere Form der Anwendung relevanter Wirkstoffe auf den menschlichen oder tierischen Körper besteht in der Zufuhr solcher Wirkstoffe mittels Spritzen direkt in das betreffende Gewebe oder mittels implantierter Depots mit den jeweiligen Wirkstoffen, entweder tiefer im Gewebe oder unmittelbar unter die Haut.Pharmaceutical agents are usually administered orally in powder form, as liquids or in the form of tablets or capsules to the human body. Another form of application of relevant active ingredients to the human or animal body is the supply of such drugs by spraying directly into the tissue in question or by means of implanted depots with the respective active ingredients, either deeper in the tissue or directly under the skin.
Zum Stand der Technik wird hierzu auf die
Zum Erreichen dieses Ziels wird im Patentanspruch 1 der
Weiter sind in dem Dokument
Zur Erreichung dieses Ziels wird im Patentanspruch 1 der
Der Erfindung liegt die Aufgabe zugrunde, ein äußerlich im Bauchnabel anwendbares Heilmittel zur Behandlung von Darmträgheit, Hämorrhoiden, Hautunreinheit und zur Förderung der Durchblutung im Kopf anzugeben.The invention has for its object to provide an externally applicable in the navel remedy for the treatment of constipation, hemorrhoids, skin impurity and to promote blood circulation in the head.
De Lösung dieser Aufgabe gelingt mit den Merkmalen im Anspruch 1, die Anwendung des Heilmittels im Bauchnabel erfolgt mit den Merkmalen im Anspruch 4.The solution to this problem is achieved with the features in
Die Erfindung wird im Folgenden näher beschrieben.The invention will be described in more detail below.
Es zeigen im Einzelnen:They show in detail:
Zuerst wird die Anwendung des erfindungsgemäßen Heilmittels im Bauchnabel erläutert.First, the application of the healing agent of the present invention in the navel will be explained.
Die Nabelschnur (Funiculus umbilicalis) verbindet bei allen Säugetieren (außer bei Kloakentieren und Beuteltieren) inklusive des Menschen den Embryo, beziehungsweise den Fetus, im Mutterleib über die Plazenta mit dem Blutkreislauf des Muttertiers, bzw. der Schwangeren. Sie stellt die Versorgung mit Nährstoffen und Sauerstoff sowie die Entsorgung von Stoffwechsel-Abbauprodukten sicher. Die menschliche Nabelschnur ist im Normalfall etwa 50 cm bis 60 cm lang und 1,5 bis 2 Zentimeter im Durchmesser dick. Sie ist meist spiralig gewunden und enthält anfänglich vier Blutgefäße. Von diesen vier Blutgefäßen bildet sich die rechte Nabelschnurvene zwischen dem 28 Tag und dem 32. Tag der Embryonalentwicklung zurück. Danach verfügt die Nabelschnur in der Regel über drei Blutgefäße, zwei Nabelarterien (arteriae umbilicales), die kohlenstoffdioxid-reiches und nährstoffarmes Blut vom Kind zur Plazenta leiten, und eine Nabelvene, die (Vena umbilicalis), die Blut von der Plazenta zum Kind leitet. Typisch für die Nabelschnur ist das gallertige Bindegewebe, das einerseits für die nötige Flexibilität verantwortlich ist und gleichzeitig vor einem Abknicken bei Biegebelastungen schützt. Es besteht aus feinen Kollagenen, wenigen Fibroblasten und großen Mengen an wasserverbindenden Hyaluronen (Wikipedia)The umbilical cord (Funiculus umbilicalis) connects in all mammals (except for cloacal animals and marsupials) including humans the embryo, or the fetus, in the womb via the placenta with the blood circulation of the mother or the pregnant woman. It ensures the supply of nutrients and oxygen as well as the disposal of metabolic waste products. The human umbilical cord is usually about 50 cm to 60 cm long and 1.5 to 2 inches in diameter thick. It is usually spiral wound and initially contains four blood vessels. Of these four blood vessels, the right umbilical vein recedes between the 28th day and the 32nd day of embryonic development. Thereafter, the umbilical cord usually has three blood vessels, two umbilical arteries, which conduct carbon dioxide-rich and nutrient-poor blood from the baby to the placenta, and a umbilical vein, which conducts blood from the placenta to the baby. Typical for the umbilical cord is the gelatinous connective tissue, which on the one hand is responsible for the necessary flexibility and at the same time protects against kinking during bending loads. It consists of fine collagens, few fibroblasts and large amounts of water-binding hyalurons (Wikipedia)
Beim Menschen wird die Nabelschnur üblicherweise nach der Geburt zweifach durchtrennt, sobald das Blut in der Nabelschnur aufgehört hat zu pulsieren. In humans, the umbilical cord is usually severed twice after birth as soon as the blood in the umbilical cord has stopped pulsing.
Wie und wie weit sich die Nabelschnur im Körper nach dem Zuwachsen des Nabels entwickelt, ist wissenschaftlich offenbar nicht von Interesse,How and how far the umbilical cord develops in the body after the umbilicus is obviously not of scientific interest
Es scheint jedoch auch in späteren Lebenszeiten eines menschlichen Wesens durchaus noch eine Wirkverbindung zwischen dem Bereich eines Bauchnabels und dem restlichen Körper zu geben die weit darüber hinaus geht was von einer Wirkverbindung eines normalen Stückchens Haut und dem restlichen Körper zu erwarten gewesen wäre.However, even in later lifetimes of a human being, there still seems to be an active connection between the region of a belly button and the rest of the body, which goes far beyond what would have been expected of an active connection between a normal piece of skin and the rest of the body.
So scheint das Kontaktieren des Bauchnabels mit pharmazeutisch wirksamen Substanzen einen erstaunlichen therapeutischen Effekt auf manchen Gebieten hervorzurufen.Thus, contacting the navel with pharmaceutically active substances seems to produce an astonishing therapeutic effect in some areas.
So wurde gefunden, dass eine Mischung aus verschiedenen Ölen, die in einen Bauchnabel geträufelt wurde, eine therapeutische Wirkung entfaltet die bei Darmträgheit, bei der Bekämpfung von Hämorrhoiden, bei der Beseitigung von Hautunreinheiten und bei der Beseitigung von Durchblutungsstörungen im Kopfbereich ( Klarheit im Kopf), erhebliche Unterstützung bietet.Thus, it has been found that a mixture of different oils that has been dropped into a navel has a therapeutic effect on constipation, in the control of hemorrhoids, in the removal of blemishes and in the removal of circulatory disorders in the head (clarity in the head) offers significant support.
Erfindungsgemäß setzt sich eine Menge von 100 ml der in Rede stehenden Ölmischung zusammen aus:
- 1. 70 ml Aprikosenöl
- 2. 10 ml Blutorangengenöl
- 3. 15 ml Lavendelöl
- 4. 5 ml Weihrauchöl
- 1. 70 ml apricot oil
- 2. 10 ml of blood orange oil
- 3. 15 ml of lavender oil
- 4. 5 ml of frankincense oil
Diese Ölmischung wird über eine Grander-Anlage geleitet, das heißt anstelle von Wasser an einem von Grander beworbenen Metallzylinder vorbeigeführt, und zur Energetisierung vor der Anwendung in Glasbehältnissen zusammen mit Saphiren, Amethysten, Rosenquarzen und Bergkristallen gelagert.This oil mixture is passed through a Grander plant, that is, passed instead of water on a Grander advertised metal cylinder, and stored for energization before use in glass containers together with sapphires, amethysts, rose quartz and rock crystals.
Der Norditaliener Unternehmer Johann Grander (1930–2012) bietet Wasser an, das an einem mit so genanntem „Informationswasser„ gefüllten Metallzylinder (meist aus Kupfer) vorbei fließt. Dadurch soll es in seiner Struktur verändert werden und besondere, nicht näher beschriebene, Eigenschaften erhalten. Angeblich soll auch ein Glas mit Grander-Wasser durch solche Informationsübertragung das Wasser an einem daneben stehenden Glas so verändern können, dass es die Eigenschaften von Grader-Wasser bekommen soll.The northern Italian entrepreneur Johann Grander (1930-2012) offers water that flows past a metal cylinder (usually made of copper) filled with so-called "information water". This should be changed in its structure and get special, unspecified, properties. Allegedly, a glass of Grander water should be able to change the water on a glass next to it by such information transfer so that it should get the properties of grader water.
Die
Die
Der Dosierbehälter
Durch die Längsachse des zylinderförmigen Dosierbehälters
Als Sonderbauform ist in der Darstellung der
Die
Die
In dieser Darstellung ist als Einzelheit die elastische Federplatte
Die
BezugszeichenlisteLIST OF REFERENCE NUMBERS
- 11
- Dosierungsvorrichtungdosing device
- 22
- Bauchbelly
- 33
- Druckknopfpush-button
- 44
- Dosierbehälterdosing
- 55
- Druckstangepushrod
- 66
- Gummiringrubber ring
- 77
- Hautskin
- 88th
- Bauchdeckeabdominal wall
- 99
- Führungshülseguide sleeve
- 1010
- Nabelbodennavel bottom
- 1111
- Druckplatten-DurchbruchPrinting plates breakthrough
- 1212
- Druckplatteprinting plate
- 1313
- PerforationsspiitzePerforationsspiitze
- 1414
- Membranboden des DosierbehältersDiaphragm bottom of the dosing tank
- 1515
- KleberGlue
- 1616
- Dichtpflastersealing pavement
- 1717
- Perforier-LochPerforating hole
- 1818
- elastische Federplatte für Perforationsspitzenelastic spring plate for perforation tips
- 1919
- Füllstands-SensorLevel sensor
- 2020
- Verschluss mit Sensorhalter und Blue-Tooth-ChipClosure with sensor holder and blue tooth chip
ZITATE ENTHALTEN IN DER BESCHREIBUNG QUOTES INCLUDE IN THE DESCRIPTION
Diese Liste der vom Anmelder aufgeführten Dokumente wurde automatisiert erzeugt und ist ausschließlich zur besseren Information des Lesers aufgenommen. Die Liste ist nicht Bestandteil der deutschen Patent- bzw. Gebrauchsmusteranmeldung. Das DPMA übernimmt keinerlei Haftung für etwaige Fehler oder Auslassungen.This list of the documents listed by the applicant has been generated automatically and is included solely for the better information of the reader. The list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions.
Zitierte PatentliteraturCited patent literature
- DE 10243917 A1 [0003, 0004] DE 10243917 A1 [0003, 0004]
- DE 102004007169 B4 [0005, 0006] DE 102004007169 B4 [0005, 0006]
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE201420007178 DE202014007178U1 (en) | 2014-09-01 | 2014-09-01 | Pharmaceutical effective oil mixture and device for its use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE201420007178 DE202014007178U1 (en) | 2014-09-01 | 2014-09-01 | Pharmaceutical effective oil mixture and device for its use |
Publications (1)
Publication Number | Publication Date |
---|---|
DE202014007178U1 true DE202014007178U1 (en) | 2014-09-29 |
Family
ID=51727751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE201420007178 Expired - Lifetime DE202014007178U1 (en) | 2014-09-01 | 2014-09-01 | Pharmaceutical effective oil mixture and device for its use |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE202014007178U1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10243917A1 (en) | 2002-09-20 | 2004-04-01 | Udo Dr. Auweiler | Device for subcutaneous delivery of a pharmaceutical product is introducible through the skin so that its subcutaneous part contains a system for controlled release of the product |
DE102004007169B4 (en) | 2003-11-28 | 2009-10-22 | Disetronic Licensing Ag | Method and device for determining a position for performing a substance delivery |
-
2014
- 2014-09-01 DE DE201420007178 patent/DE202014007178U1/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10243917A1 (en) | 2002-09-20 | 2004-04-01 | Udo Dr. Auweiler | Device for subcutaneous delivery of a pharmaceutical product is introducible through the skin so that its subcutaneous part contains a system for controlled release of the product |
DE102004007169B4 (en) | 2003-11-28 | 2009-10-22 | Disetronic Licensing Ag | Method and device for determining a position for performing a substance delivery |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE202013001998U1 (en) | Catheter, in particular for the treatment of prostate and / or bladder, and kit containing this catheter | |
DE2623291A1 (en) | IMPLANT FOR LONG-TERM TREATMENT OF A LIVING BEING | |
DE1882100U (en) | DEVICE WITH A CANULE OR PROBE FOR THE TREATMENT OF PARTICULAR DISEASES OF THE VAGINARY WITH AEROSOLS. | |
DE102009014369A1 (en) | Dummy dummy and process for its preparation | |
DE1498679A1 (en) | Method and device for the production of microscopic preparations from cell material samples | |
DE102014012691B4 (en) | Device for applying a pharmaceutically active oil mixture | |
DE202014007178U1 (en) | Pharmaceutical effective oil mixture and device for its use | |
DE60016809T2 (en) | EQUIPMENT FOR DEPONING MEDICAMENTS IN THE MOUTH | |
EP3369397B1 (en) | Assembly for ultrasound-assisted manipulation at the female reproductive organs of large mammals | |
DE202008018310U1 (en) | WARNING DEVICE | |
EP3494926A1 (en) | Implant with reservoir | |
DE1566299B1 (en) | Capsule for subcutaneous implants | |
Gallagher | Distribution of testicular comb growth stimulating principle in tissues | |
Schaub et al. | Kognitiv-psychoedukative Gruppenintervention bei stationären Patienten mit depressiven Erkrankungen–Ergebnisse einer prospektiven Pilotstudie | |
EP0166979B1 (en) | Apparatus for receiving and conducting human ovula | |
DE2125464C3 (en) | Device for the prophylactic or therapeutic treatment of animals by applying active ingredients | |
Gelardini | Exegetische Analyse des Markusevangeliums | |
DE102007023021A1 (en) | Therapeutic patch for trigger and acupuncture points as well as for meridian therapy | |
Hegglin et al. | Maligne Tumoren bei Dermatomyositis | |
Starck et al. | HRS expert consensus (2017) lead management and extraction of cardiac implantable electronic devices as well as EHRA expert consensus (2018) on scientific analysis of lead extraction: Comments of the Working Group on Heart Rhythm Disorders of the German Society for Thoracic, Cardiac and Vascular Surgery | |
DE874200C (en) | Ampoule syringe for medicines to be mixed before use | |
DE10243917A1 (en) | Device for subcutaneous delivery of a pharmaceutical product is introducible through the skin so that its subcutaneous part contains a system for controlled release of the product | |
Kubota et al. | Zytologische Untersuchungen der Mantelzellen im menschlichen Spinalganglion. | |
Hypnonarkose | R. FREY | |
DE102019130577A1 (en) | Ostomy plate change adapter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R086 | Non-binding declaration of licensing interest | ||
R207 | Utility model specification |
Effective date: 20141106 |
|
R150 | Utility model maintained after payment of first maintenance fee after three years | ||
R151 | Utility model maintained after payment of second maintenance fee after six years | ||
R152 | Utility model maintained after payment of third maintenance fee after eight years | ||
R071 | Expiry of right |